1-3 of 3
Clinton E. Leysath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CXCR4 Up-Regulation by Imatinib Mesylate Induces CML Cell Migration to Bone Marrow Stroma and Promotes Survival of Chemoresistant Quiescent CML Cells.

Yoko Tabe, MD, PhD, Linhua Jin, M.D., Ph.D., Clinton E. Leysath, Shinya Kimura, M.D., Ph.D., Hagop Kantarjian, M.D., Michael Andreeff, M.D., Ph.D., Marina Konopleva, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2123.
https://doi.org/10.1182/blood.V108.11.2123.2123
Published: 2006
Journal Articles

Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Brief Report
Michele Milella, Zeev Estrov, Steven M. Kornblau, Bing Z. Carter, Marina Konopleva, Ana Tari, Wendy D. Schober, David Harris, Clinton E. Leysath, Gabriel Lopez-Berestein, Ziwei Huang, Michael Andreeff
Journal: Blood
Blood (2002) 99 (9): 3461–3464.
https://doi.org/10.1182/blood.V99.9.3461
Published: 2002
Journal Articles

Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia

Marina Konopleva, Twee Tsao, Peter Ruvolo, Irina Stiouf, Zeev Estrov, Clinton E. Leysath, Shourong Zhao, David Harris, Shirong Chang, C. Ellen Jackson, Mark Munsell, Nanjoo Suh, Gordon Gribble, Tadashi Honda, W. Stratford May, Michael B. Sporn, Michael Andreeff
Journal: Blood
Blood (2002) 99 (1): 326–335.
https://doi.org/10.1182/blood.V99.1.326
Published: 2002